Novacta presents preclinical data on its novel lantibiotic NVB-302 in C. difficile infection Oct. 2, 2009
Novel glycopetide antibacterial agent LT-00029 shows potent in vitro and in vivo activity Oct. 2, 2009
Tetraphase presents novel, potent tetracycline and pentacycline analogues at ICAAC meeting Oct. 2, 2009
Promising phase I and II clinical data on NGR-hTNF in solid tumors disclosed at ECCO/ESMO Oct. 1, 2009
Arasertaconazole nitrate displays potent antifungal/antibacterial activity in vitro and in vivo Oct. 1, 2009
Multikinase inhibitor regorafenib shows promising antitumor activity in phase II trial in RCC Oct. 1, 2009
RSS